Pharma & Biotech
Septodont Company Overview
Septodont Industry: Pharma
Located: Saint-Maur-des-Fossés, France
Revenue: 234 million €
Headcount: 1,800 employees worldwide
“Septodont has a very large product portfolio. Assessing the benefit/effort of maintaining legacy products was an ongoing challenge. Sciforma consolidates the effort associated with each of the products, enabling us to better estimate the cost of continuing with them. This supports strategic thinking and decisions on whether or not it is worthwhile to keep such and such a product in the portfolio.”
Head of Programs – Pharmaceutical Affairs Department
Septodont is an independent laboratory specializing in the development, manufacturing, and distribution of dental products. To them, it is critical to continue to innovate in order to deliver new products while also maintaining existing products on the various markets they’re active in.
The multiplication of innovative projects, coupled with changing regulatory requirements, were complicating the management of this diverse portfolio. Further, lacking a consolidated view of project-related tasks, it had become challenging to set clear priorities for the teams. With several departments involved, the lack of visibility on the work to be done given the available capacity sometimes triggered misunderstandings across functions and weighed on overall efficiency.
Deploying Sciforma’s PPM software in 2021 has enabled Septodont to improve both tactical and strategic decisions, as well as the management of the product portfolio.
Septodont chose to partner with consultancy firm Noveane to successfully implement the solution.
The Benefits for Septodont
Visibility and Transparency for Forward-Looking Management
Now that all the data associated with product development and registration is automatically consolidated in Sciforma, everyone is notified in real time of upcoming deadlines and can therefore anticipate resource needs and possible new hires. As a result, Septodont is now empowered to prepare 6-month capacity plans. Most importantly, the company now has a 3-year overview of product-related activities.
Streamlined Product Portfolio Management
The deployment of the new system provided the opportunity to tweak the processes and workflows used across the departments involved. The department clarified and optimized processes that showed room for improvement, and standardized project and portfolio management practices.
Highlighting resource over- and under-allocations has improved the internal organization of the various departments (R&D, Legal, Medical, Project Management) as well as the quality of interactions. Additionally, the formalization of multiple cross-department governance bodies has gone a long way toward improving the process for making portfolio decisions.
More Insightful and Reliable Strategic Decisions
Because the data from Sciforma feeds into the steering committees, executive managers can easily make decisions based on clear and objective information.
With better understanding came faster and simpler decisions about project prioritization, rescheduling, and reallocation. This has also improved the Total Cost of Ownership estimates for the various products in the portfolio, enabling Septodont to optimize its product mix.
“Because the data from Sciforma feeds into the steering committees, executive managers can easily make decisions based on clear and objective information. With better understanding came faster and simpler decisions about project prioritization, rescheduling, and reallocation.”
Head of Programs Pharmaceutical Affairs Department, Septodont